Hie inhibitory function of CD4CD25+T regulatory cells is impaired in relapsing-remitting multiple sclerosis but not in primary progressive multiple sclerosis

被引：0
作者：
Putzki, Norman [1 ]
Kamou, Roulat [1 ]
Kumar, Manoj [1 ]
Kreuzfelder, Ernst [1 ]
机构：
[1] Univ Clin Essen, Dept Neurol, Essen, Germany
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [31] Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis
    Ratzer, R.
    Sondergaard, H. B.
    Sorensen, P. S.
    Christensen, J. C.
    Sellebjerg, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 131 - 132
  • [32] Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis
    Ratzer, R.
    Sondergaard, H. B.
    Christensen, J. Romme
    Bornsen, L.
    Borup, R.
    Sorensen, P. S.
    Sellebjerg, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (14) : 1841 - 1848
  • [33] IFNbeta-1a therapy enhances CD4+ regulatory T-cells function in a longitudinal study in relapsing-remitting multiple sclerosis patients
    de Andrés, C
    Aristimuno, C
    de las Heras, V
    Navarro, J
    Bartolomé, M
    Martínez-Ginés, M
    Arroyo, R
    Giménez-Roldán, S
    Fernández-Cruz, E
    Sánchez-Ramón, S
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S80 - S81
  • [34] Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis
    Burgetova, A.
    Dusek, P.
    Vaneckova, M.
    Horakova, D.
    Langkammer, C.
    Krasensky, J.
    Sobisek, L.
    Matras, P.
    Masek, M.
    Seidl, Z.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2017, 38 (06) : 1079 - 1086
  • [35] CD95 expression on peripheral blood T-lymphocytes in patients with relapsing-remitting, primary and secondary progressive multiple sclerosis
    Petelin, Z.
    Brinar, V. V.
    Zurak, N.
    Milat, D.
    Petravic, D.
    Batinic, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 314 - 314
  • [36] Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study
    de Antonio, Luis A. Rodriguez
    Cuberta-Gonzalez, Ines
    Garcia-Castanon, Inmaculada
    Oreja-Guevara, Celia
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
  • [37] Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis
    Carotenuto, A.
    Costabile, T.
    Moccia, M.
    Falco, F.
    Scala, M. R.
    Russo, C., V
    Sacca, F.
    De Rosa, A.
    Lanzillo, R.
    Morra, V. Brescia
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 1 - 6
  • [38] Effect of IFN-β therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): A preliminary study
    Namdar, Afshin
    Nikbin, Behroz
    Ghabaee, Mojde
    Bayati, Asghar
    Izad, Maryam
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2010, 218 (1-2) : 120 - 124
  • [39] NEDA as a predictor of conversion to secondary progressive multiple sclerosis in patients with relapsing-remitting multiple sclerosis
    Kappos, L.
    Stefano, N. D.
    Sormani, M. P.
    Giovannoni, G.
    Haring, D.
    Tomic, D.
    Meier, D. Piani
    Chitnis, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 638 - 639
  • [40] Depressive symptoms and suicidal ideation in progressive multiple sclerosis compared to relapsing-remitting multiple sclerosis
    Knowles, L.
    Esselman, E.
    Turner, A.
    Phillips, K.
    Herring, T.
    Alschuler, K.
    Ehde, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 634 - 634
12345